BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1408136)

  • 1. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase.
    Reynolds PJ; Hurley TR; Sefton BM
    Oncogene; 1992 Oct; 7(10):1949-55. PubMed ID: 1408136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lymphocyte-specific tyrosine protein kinase p56lck.
    Veillette A; Abraham N; Caron L; Davidson D
    Semin Immunol; 1991 May; 3(3):143-52. PubMed ID: 1909593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
    Yamaguchi H; Hendrickson WA
    Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of GAP and GAP-associated proteins in lymphoid and fibroblast cells expressing lck.
    Ellis C; Liu XQ; Anderson D; Abraham N; Veillette A; Pawson T
    Oncogene; 1991 Jun; 6(6):895-901. PubMed ID: 1906156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.
    Choi YB; Kim CK; Yun Y
    J Immunol; 1999 Nov; 163(10):5242-9. PubMed ID: 10553045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation.
    Veillette A; Fournel M
    Oncogene; 1990 Oct; 5(10):1455-62. PubMed ID: 2250907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N; Miceli MC; Parnes JR; Veillette A
    Nature; 1991 Mar; 350(6313):62-6. PubMed ID: 1706070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of tripartite chimeras between Src and Lck.
    Kashishian A; MacAuley A; Cooper JA
    Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
    J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells.
    Ogawa S; Toyoshima H; Kozutsumi H; Hagiwara K; Sakai R; Tanaka T; Hirano N; Mano H; Yazaki Y; Hirai H
    Oncogene; 1994 Jun; 9(6):1669-78. PubMed ID: 8183562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P56lck A lymphocyte specific protein tyrosine kinase: activation, regulation and signal transduction.
    Fischer S; Marie-Cardine A; Ramos-Morales F; Bougeret C; Soula M; Maridonneau-Parini I; Benarous R
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):605-9. PubMed ID: 7981618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-cell lines.
    Lee JM; Fournel M; Veillette A; Branton PE
    Oncogene; 1996 Jan; 12(2):253-63. PubMed ID: 8570203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding affinities of the SH2 domains of ZAP-70, p56lck and Shc to the zeta chain ITAMs of the T-cell receptor determined by surface plasmon resonance.
    Labadia ME; Ingraham RH; Schembri-King J; Morelock MM; Jakes S
    J Leukoc Biol; 1996 May; 59(5):740-6. PubMed ID: 8656061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Raf-1 serine-threonine kinase is a substrate for the p56lck protein tyrosine kinase in human T-cells.
    Thompson PA; Ledbetter JA; Rapp UR; Bolen JB
    Cell Growth Differ; 1991 Dec; 2(12):609-17. PubMed ID: 1687313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.